<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:npr="https://www.npr.org/rss/" xmlns:nprml="https://api.npr.org/nprml" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>NPR: boosters</title>
    <link>https://www.npr.org/templates/story/story.php?storyId=1024851591</link>
    <description>boosters</description>
    <language>en</language>
    <copyright>Copyright 2024 NPR - For Personal Use Only</copyright>
    <generator>Story API Shim 1.2.24</generator>
    <lastBuildDate>Wed, 07 May 2025 00:09:45 -0400</lastBuildDate>
    <image>
      <url>https://media.npr.org/images/podcasts/primary/npr_generic_image_300.jpg?s=200</url>
      <title>NPR: boosters</title>
      <link>https://www.npr.org/tags/1024851591/boosters</link>
    </image>
    <item>
      <title>The new COVID boosters are coming: Here&apos;s what you need to know</title>
      <description>Updated versions of the mRNA vaccines roll out this week. Experts say they offer good protection against current COVID variants. Who should get them, and when&apos;s the best time to roll up your sleeve?</description>
      <pubDate>Wed, 13 Sep 2023 05:01:00 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2023/09/13/1198803134/covid-boosters-updated-vaccines-fda-cdc</link>
      <guid>https://www.npr.org/sections/health-shots/2023/09/13/1198803134/covid-boosters-updated-vaccines-fda-cdc</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2023/09/12/gettyimages-1237588736_custom-7cea31dd1630ee504005bde710fcc6fea4c243a2.jpg' alt='Experts say the new COVID boosters are a much closer match to currently circulating variants than prior vaccines and boosters.'/><p>Updated versions of the mRNA vaccines roll out this week. Experts say they offer good protection against current COVID variants. Who should get them, and when's the best time to roll up your sleeve?</p><p>(Image credit: Frederick J. Brown)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1198803134' />]]></content:encoded>
      <dc:creator>Maria Godoy</dc:creator>
    </item>
    <item>
      <title>Coronavirus FAQs: How worrisome is the new variant? How long do boosters last?</title>
      <description>Readers are curious about the new variant, currently known a BA.2.86. Also: Lots of questions about boosters. Can you get it at the same time as a flu shot? And how long does protection last?</description>
      <pubDate>Fri, 25 Aug 2023 17:17:05 -0400</pubDate>
      <link>https://www.npr.org/sections/goatsandsoda/2023/08/25/1195592942/coronavirus-faqs-how-worrisome-is-the-new-variant-how-long-do-boosters-last</link>
      <guid>https://www.npr.org/sections/goatsandsoda/2023/08/25/1195592942/coronavirus-faqs-how-worrisome-is-the-new-variant-how-long-do-boosters-last</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2023/08/24/covid-booster-faq_custom-7f0fd5dd2794068831a14b900c110a9f9c250014.jpg' alt='A booster vaccine is administered on the Indonesian resort island of Bali.'/><p>Readers are curious about the new variant, currently known a BA.2.86. Also: Lots of questions about boosters. Can you get it at the same time as a flu shot? And how long does protection last?</p><p>(Image credit: Sonny Tumbelaka)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1195592942' />]]></content:encoded>
      <dc:creator>Fran Kritz</dc:creator>
    </item>
    <item>
      <title>Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster?</title>
      <description>Maybe it&apos;s not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.</description>
      <pubDate>Fri, 11 Aug 2023 12:44:26 -0400</pubDate>
      <link>https://www.npr.org/sections/goatsandsoda/2023/08/11/1193229029/coronavirus-faq-is-it-wiser-to-get-a-booster-now-or-wait-for-the-new-fall-booste</link>
      <guid>https://www.npr.org/sections/goatsandsoda/2023/08/11/1193229029/coronavirus-faq-is-it-wiser-to-get-a-booster-now-or-wait-for-the-new-fall-booste</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2023/08/10/gettyimages-1246522670_custom-081731c2ede66cbd028d9a31bb826230f931d9bb.jpg' alt='A COVID booster is administered in Jakarta, Indonesia.'/><p>Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.</p><p>(Image credit: Eko Siswono Toyudho)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1193229029' />]]></content:encoded>
      <dc:creator>Fran Kritz</dc:creator>
    </item>
    <item>
      <title>Popular COVID FAQs in 2022: Outdoor risks, boosters, 1-way masking, faint test lines</title>
      <description>Let&apos;s revisit some of 2022&apos;s still relevant queries. Like: Does one-way masking help? What&apos;s the risk of outdoor transmission? What&apos;s up with faint lines on tests?</description>
      <pubDate>Tue, 20 Dec 2022 09:19:58 -0500</pubDate>
      <link>https://www.npr.org/sections/goatsandsoda/2022/12/20/1142006506/popular-covid-faqs-in-2022-outdoor-risks-boosters-1-way-masking-faint-test-lines</link>
      <guid>https://www.npr.org/sections/goatsandsoda/2022/12/20/1142006506/popular-covid-faqs-in-2022-outdoor-risks-boosters-1-way-masking-faint-test-lines</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2022/12/19/outdoor-faq-poster_custom-7da9545ac8915d0baaeaf7f639c6040acd32b77d.jpg' alt='Print a poster version of this comic to hang up on your fridge or give away to friends. <a href="https://drive.google.com/file/d/13ggzz9qS2c6rQCXg3VCUo9iip3i1XtWG/view?usp=sharing">Download the poster here.</a>'/><p>Let's revisit some of 2022's still relevant queries. Like: Does one-way masking help? What's the risk of outdoor transmission? What's up with faint lines on tests?</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1142006506' />]]></content:encoded>
      <dc:creator>Marc Silver</dc:creator>
    </item>
    <item>
      <title>CDC recommends 2nd COVID boosters for some older and immunocompromised people</title>
      <description>People who are 50 and older and certain immunocompromised individuals may get a second Pfizer-BioNTech or Moderna COVID-19 vaccine booster four months after they received the first.</description>
      <pubDate>Sun, 27 Mar 2022 21:06:01 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2022/03/27/1089072803/the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up</link>
      <guid>https://www.npr.org/sections/health-shots/2022/03/27/1089072803/the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2022/03/27/gettyimages-1237388067_custom-fba6a1d94ee3ee29c07a8ae831d414f441005c0a.jpg' alt='As immunity wanes fom the first booster, the FDA has now authorized a second shot for people 50 and older and some immunocompromised people. The CDC has also recommended that people get the booster.'/><p>People who are 50 and older and certain immunocompromised individuals may get a second Pfizer-BioNTech or Moderna COVID-19 vaccine booster four months after they received the first.</p><p>(Image credit: FREDERIC J. BROWN)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1089072803' />]]></content:encoded>
      <dc:creator>Rob Stein</dc:creator>
    </item>
    <item>
      <title>J&amp;J is asking the FDA to authorize its COVID-19 booster shots</title>
      <description>Johnson &amp; Johnson asks the Food and Drug Administration to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign.</description>
      <pubDate>Tue, 05 Oct 2021 10:39:20 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/10/05/1043332922/johnson-vaccine-booster-fda-authorization-jj</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/10/05/1043332922/johnson-vaccine-booster-fda-authorization-jj</guid>
      <content:encoded><![CDATA[<p>Johnson & Johnson asks the Food and Drug Administration to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1043332922' />]]></content:encoded>
      <dc:creator>The Associated Press</dc:creator>
    </item>
    <item>
      <title>Moderna Has Asked The FDA To Authorize A Booster Of Its COVID-19 Vaccine</title>
      <description>Moderna submitted data from 344 volunteers who got a third shot of the vaccine six months after their first two doses. The additional shot significantly boosted immunity, the company said.</description>
      <pubDate>Wed, 01 Sep 2021 20:16:28 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/09/01/1033474298/moderna-fda-covid-19-booster-shot</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/09/01/1033474298/moderna-fda-covid-19-booster-shot</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/09/01/gettyimages-1332309540_custom-e11ff474b0c47ee0c556152cb74db9718c149192.jpg' alt='A third shot of the Moderna vaccine boosts protection across age groups, notably in older adults, the company says.'/><p>Moderna submitted data from 344 volunteers who got a third shot of the vaccine six months after their first two doses. The additional shot significantly boosted immunity, the company said.</p><p>(Image credit: Juana Miyer)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1033474298' />]]></content:encoded>
      <dc:creator>Jane Greenhalgh</dc:creator>
    </item>
    <item>
      <title>Antibody Tests Should Not Be Your Go-To For Checking COVID Immunity</title>
      <description>Worries about waning immunity and talk of COVID booster shots has some Americans checking their antibody levels to see if they&apos;re protected. But scientists warn blood tests don&apos;t tell the full story.</description>
      <pubDate>Sat, 28 Aug 2021 07:00:00 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2021/08/28/1031287076/antibody-tests-should-not-be-your-go-to-for-checking-covid-immunity</link>
      <guid>https://www.npr.org/sections/health-shots/2021/08/28/1031287076/antibody-tests-should-not-be-your-go-to-for-checking-covid-immunity</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/08/27/gettyimages-1229093007-7dc490abde3eac8fbdd487aa033a41391d54614a.jpg' alt='Testing your antibody levels to get a sense of your COVID-19 protection may be tempting, especially as you wait for a booster shot. But scientists say these widely available tests can't tell you the full story, at least not yet.'/><p>Worries about waning immunity and talk of COVID booster shots has some Americans checking their antibody levels to see if they're protected. But scientists warn blood tests don't tell the full story.</p><p>(Image credit: Naveen Sharma)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1031287076' />]]></content:encoded>
      <dc:creator>Will Stone</dc:creator>
    </item>
    <item>
      <title>Why A Push For Boosters Could Make The Pandemic Even Worse</title>
      <description>Public health figures believe a focus on boosters for the already vaccinated will hasten the emergence of new variants among the billions of unvaccinated people — including a vaccine-resistant strain.</description>
      <pubDate>Wed, 18 Aug 2021 15:45:00 -0400</pubDate>
      <link>https://www.npr.org/sections/goatsandsoda/2021/08/18/1028941909/why-a-push-for-boosters-could-make-the-pandemic-even-worse</link>
      <guid>https://www.npr.org/sections/goatsandsoda/2021/08/18/1028941909/why-a-push-for-boosters-could-make-the-pandemic-even-worse</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/08/18/gettyimages-1234612181_custom-25bcc954424386d95f329cf781d7d9bc9268b88c.jpg' alt='People line up last week to receive COVID-19 vaccines in Kampala, Uganda, after weeks of no supply. In Uganda, only 2.2% of the population had received one dose of a vaccine as of Aug. 15.'/><p>Public health figures believe a focus on boosters for the already vaccinated will hasten the emergence of new variants among the billions of unvaccinated people — including a vaccine-resistant strain.</p><p>(Image credit: Hajarah Nalwadda)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1028941909' />]]></content:encoded>
      <dc:creator>Michaeleen Doucleff</dc:creator>
    </item>
    <item>
      <title>Why WHO Is Calling For A Moratorium On COVID Vaccine Boosters</title>
      <description>The director general is asking for a halt for at least two months. His hope is to use all available doses to vaccinate 10% of the population in every country by the end of September.</description>
      <pubDate>Wed, 04 Aug 2021 19:15:00 -0400</pubDate>
      <link>https://www.npr.org/sections/goatsandsoda/2021/08/04/1019780576/why-who-is-calling-for-a-moratorium-on-covid-vaccine-boosters</link>
      <guid>https://www.npr.org/sections/goatsandsoda/2021/08/04/1019780576/why-who-is-calling-for-a-moratorium-on-covid-vaccine-boosters</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/08/04/gettyimages-1234403612_custom-63f3bc96ef0a1b26e5c63e0ee5badf7e39b29e1f.jpg' alt='The director of WHO now says that a booster moratorium should be in force until 10% of the population in all countries is vaccinated. Israel had previously announced plans to give a third Pfizer dose to residents age 60 and up after an uptick in COVID cases. Above: Administering a booster on August 2 in Tel Aviv.'/><p>The director general is asking for a halt for at least two months. His hope is to use all available doses to vaccinate 10% of the population in every country by the end of September.</p><p>(Image credit: Kobi Wolf)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1019780576' />]]></content:encoded>
      <dc:creator>Jason Beaubien</dc:creator>
    </item>
  </channel>
</rss>